Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.
about
The epidemiological impact of antiretroviral use predicted by mathematical models: a review.HIV-associated lung infections and complications in the era of combination antiretroviral therapy.Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohortsUse of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infectionEvaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies.A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or CAssociation between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional studyHerpes zoster among persons living with HIV in the current antiretroviral therapy era.Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screeningEnrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007.Random survival forests for competing risks.Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressors.Reduced risk of prostate cancer in U.S. Men with AIDS.Trends in hospitalizations among children and young adults with perinatally acquired HIV.Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival.Gonorrhoea and chlamydia testing rates of HIV-infected men: low despite guidelinesImmunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infectionPerformance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.Long-term CD4+ cell count in response to combination antiretroviral therapy.Immune status at presentation for HIV clinical care in Rio de Janeiro and BaltimoreIncreased gonorrhoea and chlamydia testing did not increase case detection in an HIV clinical cohort 1999-2007.Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice.Control of medical comorbidities in individuals with HIVIs the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?Improvement in the health of HIV-infected persons in care: reducing disparities.Trust in physicians and racial disparities in HIV careLower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation.Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults.Antiretroviral Therapy Use, Medication Adherence, and Viral Suppression Among PLWHA with Panic Symptoms.Alcohol consumption and CD4 T-cell count response among persons initiating antiretroviral therapyIs patients' preferred involvement in health decisions related to outcomes for patients with HIV?Hip bone geometry in HIV/HCV-co-infected men and healthy controls.Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicenter cohort study.
P2860
Q24814633-8C3852F3-FFD7-4757-850F-7999D76B1927Q27693307-B4732276-4C3A-4437-9BF0-705E1A012B73Q28477883-A095A057-D4F1-449A-AAE2-C257ED01D184Q28743210-48906DC5-E21C-447E-AF61-372DE83F097AQ33638209-65C95307-2EC3-429D-A888-1EF1A44BA9C9Q33812743-1AE4B498-D780-4330-8673-22CA45A08203Q33897087-4A936514-5DD1-49F6-A022-ECF1F06A405CQ33940800-420420CC-A5D7-4FDB-9494-31CAEBFD0C8BQ33963850-3CBCC19D-77D5-48A5-8E42-2F1A43CC54ADQ34067651-4D3856D4-539C-49F2-925F-E8D78D22B679Q34132884-70B6C820-E10D-48D8-A1D2-DAF4A9F27DF3Q34205686-97607B84-1840-46C3-8B97-8FE55C76A7BDQ34213876-BEF01845-A305-4790-9BD6-966FA7FED26EQ34235347-FD50339D-2274-453C-8860-AAC5CCA5CD2EQ34284388-0173A39E-F1B8-44B7-A3E9-EBF191710B83Q34292990-959415F5-6B47-4D06-AB09-B1141B5DED4FQ34432664-1F0D605E-9DDB-4A02-88D9-88757E894D1BQ34598155-7B7748D3-F4E5-4D67-AC36-4A89FD77586DQ34717877-9A363085-970F-4877-9276-2499148B2B96Q34724413-809060F7-08F9-4410-956A-79BE0D2BDD28Q34731485-8B58E615-BA97-4314-89D6-75EF480AC2A9Q34806379-0DD90A65-F100-4FBA-A1AC-AF1D0A02214DQ34974095-6301B386-04C2-4D40-A31C-9122CB4508B2Q35040559-2DB5128F-65A6-4612-AFFD-926DD1CFB12AQ35080053-6FC15646-3C28-46C4-B1BC-505AB51BAD60Q35138526-3C88AC52-66BC-4C0C-B375-D3A5A5F5A16BQ35205910-C2176358-0F12-4BCB-8C9B-8083D113E943Q35216270-60C9C5A0-CC73-4D52-A46E-9E2C47C03736Q35452272-5F1EBAC9-E005-472B-A900-466F965C61ECQ35576194-CB42678A-A0E9-448A-9617-83F2C0BEF492Q35901434-BB2A5C08-5588-4529-8C1E-F3FB9AF6F959Q36303074-9C42FD33-449B-4042-9759-348769040A33Q36321589-658C5AB9-4488-4549-AB8F-1EABD68897AEQ36414171-AE5A0CC4-47E6-4BB3-9DA6-A25076A6C0FFQ36461597-44AEF906-1B99-40CC-BF72-49AB528BF91CQ36461775-769043DD-6DE3-41C7-B036-145C2D5012B9Q36522288-B68566E0-F601-460F-B259-947AF8C70B26Q36551927-47C6F232-279B-4D6B-BE40-304916313913Q36600009-DB0362B9-7EBE-40A5-9C7E-BF0089E21C7DQ36634843-8E319F29-FD72-49F1-A860-E5BC931FF8EC
P2860
Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Understanding the clinical and ...... HIV clinical practice cohort.
@en
type
label
Understanding the clinical and ...... HIV clinical practice cohort.
@en
prefLabel
Understanding the clinical and ...... HIV clinical practice cohort.
@en
P1476
Understanding the clinical and ...... s HIV clinical practice cohort
@en
P2093
P304
P356
10.1097/00042560-199801001-00011
P407
P478
17 Suppl 1
P577
1998-01-01T00:00:00Z